The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast
DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009.
Ted Karkus, Chairman and CEO, will provide a Compa...
Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study
DOYLESTOWN, Pa., July 22 /PRNewswire-FirstCall/ --
Quigley Pharma Inc., a wholly-owned subsidiary of The
Quigley Corporation (Nasdaq: QGLY ) www.quigleyco.com , today announced the results from its Phase IIb double-blind, placebo-controlled, study of topical compound QR-333 for the tre...
Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
DOYLESTOWN, Pa., July 17 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Ted Karkus, Chairman of the Board of The
Quigley Corporation, has been appointed Chief Executive Officer by the Board of Directors of the Compan...
Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary
DOYLESTOWN, Pa., July 10 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Dr. Richard Rosenbloom has resumed providing services to the Company's
Quigley Pharma subsidiary. Dr. Rosenbloom had been temporarily suspended from t...
Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
DOYLESTOWN, Pa., June 18 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Ted Karkus, Chairman of the Board of The
Quigley Corporation, has been appointed Interim Chief Executive Officer by the Board of Directors of the Company. Mr...
Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
DOYLESTOWN, Pa., June 15 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that on Friday, June 12, 2009, the United States District Court for the Eastern District of Pennsylvania issued a decision and order rejecting the last of t...
The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
DOYLESTOWN, Pa. June 1 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ), www.quigleyco.com , today announced that IVS Associates, Inc., the inspector of election for Quigley's 2009 annual meeting of shareholders, issued its final report, showing that Ted Karkus' seve...
Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
DOYLESTOWN, Pa., May 19 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that it has uncovered an improper financial relationship between Ted Karkus and the Company's
Quigley Pharma, Inc. wholly-owned subsidiary COO, Dr. Richard A. ...
Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Company's Latest Announcement
WOODMERE, N.Y., May 19 /PRNewswire/ -- The
Quigley Corporation (Nasdaq: QGLY ) announced yesterday that its Board was exploring various options, including hiring an investment banker and exploring "strategic alternatives".
Ted Karkus, Mark Burnett, John DeShazo, Mark Frank, Louis Gleckel,...
The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
DOYLESTOWN, Pa., May 18 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QG L Y), www.quigleyco.com , today announced an update on the Company's possible alternative strategies going forward following the Company's recent announcement regarding the unexpected positive findi...
Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago
DOYLESTOWN, Pa., June 12 /PRNewswire-FirstCall/ -- The
Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced the resignation of Guy J.
Quigley as Chairman, President and Chief Executive Officer of the Company. The resignation is effective immediately, followin...
In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division
WOODMERE, N.Y., May 19 /PRNewswire/ -- In an eleventh-hour attempt to smear Ted Karkus, The
Quigley Corporation (Nasdaq: QGLY ) has issued a press release claiming that there was some improper financial arrangement between Dr. Richard Rosenbloom, a key staff member of a subsidiary of Quigley, ...
The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
DOYLESTOWN, Pa., July 31 /PRNewswire-FirstCall/ -- The Quigley
Corporation (Nasdaq: QGLY ) today reported net sales from continuing
operations of $2.1 million, for the second quarter ended June 30, 2008,
compared to $2.2 million reported for the second quarter ended June 30,
2007. For the six...
Quigley Corporation Releases Update on Quigley Pharma's Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
DOYLESTOWN, Pa., Sept. 11 /PRNewswire-FirstCall/ -- The Quigley
Corporation (Nasdaq: QGLY ) today issued an update on a Phase IIb Clinical
Study of QR-333 on Diabetic Peripheral Neuropathy by its wholly owned
subsidiary,
Quigley Pharma, http://www.QuigleyPharma.com . The update on the study...
International Survey Shows People Over Forty Ignore Risk of Blindness
...cus, Nov. 1 2004 (2). Congdon NG, Friedman DS, Lietman T. Important Causes of Visual
Impairment in the World Today. JAMA. 2003; 290: 2057-2060. (3).
quigley HA, Broman AT. The number of people with glaucoma
worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267 (4). Lee PP, Walt JG, Doyle JJ et al....